Catalyst Wire Dossier Catalyst Wire Dossier

Influenza Vaccine (cell culture-based, inactivated)

influenza vaccine, cell culture-based, inactivated · Novartis Vaccines
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Influenza Vaccine (cell culture-based, inactivated), covering 2011-10-12 to 2011-10-12. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Immunogenicity of One Dose of a Surface, Antigen, Inactivated, Influenza Vaccine Produced in Mammalian Cell Culture Administered to Adult and Elderly Subjects [Phase 3]

See pricing